INmune Bio, Inc.
Hedge Funds Holdings
Last updated:
INmune Bio, Inc.‘s stocks are currently a part of 18 hedge funds’ portfolios, which represents 3.82% of the total amount of its stocks outstanding. This makes up a total of 685.51K shares of INmune Bio, Inc.. Compared to the previous quarter, the number fell by -58.33% or -959.49K shares fewer. As for the holding position changes, 33.33% (6) of current hedge fund investors increased the number of shares held, 33.33% (6) of current holders sold a part of the shares held, and 11.11% (2) closed the holdings completely. 4 hedge funds are new holders of INmune Bio, Inc. stock in Q1 2023, it is 22.22% of total holders.
Hedge funds holding INmune Bio (Q1 2019 – Q1 2023)
Q1 2019 | 5 |
---|---|
Q2 2019 | 7 |
Q3 2019 | 10 |
Q4 2019 | 10 |
Q1 2020 | 10 |
Q2 2020 | 12 |
Q3 2020 | 26 |
Q4 2020 | 25 |
Q1 2021 | 32 |
Q2 2021 | 39 |
Q3 2021 | 38 |
Q4 2021 | 41 |
Q1 2022 | 31 |
Q2 2022 | 34 |
Q3 2022 | 31 |
Q4 2022 | 31 |
Q1 2023 | 18 |
Hedge funds changes in INmune Bio positions (Q1 2019 – Q1 2023)
Q1 2019 | 5 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q2 2019 | 4 | 1 | 1 | 2 | -1 |
Q3 2019 | 4 | 4 | 0 | 1 | 1 |
Q4 2019 | 3 | 2 | 0 | 3 | 2 |
Q1 2020 | 4 | 3 | 0 | 1 | 2 |
Q2 2020 | 4 | 2 | 2 | 3 | 1 |
Q3 2020 | 16 | 4 | 3 | 2 | 1 |
Q4 2020 | 10 | 6 | 4 | 10 | -5 |
Q1 2021 | 10 | 15 | 2 | 3 | 2 |
Q2 2021 | 17 | 7 | 5 | 10 | 0 |
Q3 2021 | 7 | 16 | 7 | 8 | 0 |
Q4 2021 | 8 | 16 | 11 | 5 | 1 |
Q1 2022 | 1 | 9 | 9 | 10 | 2 |
Q2 2022 | 5 | 9 | 10 | 3 | 7 |
Q3 2022 | 4 | 9 | 7 | 6 | 5 |
Q4 2022 | 4 | 13 | 7 | 2 | 5 |
Q1 2023 | 4 | 6 | 6 | 2 | 0 |
Hedge funds changes in INmune Bio stock options (Q1 2019 – Q1 2023)
Q1 2019 | 0 | 0 |
---|---|---|
Q2 2019 | 0 | 0 |
Q3 2019 | 0 | 0 |
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 0 | 0 |
Q4 2020 | 0 | 0 |
Q1 2021 | 0 | 0 |
Q2 2021 | 1,036,000 | 972,000 |
Q3 2021 | 2,837,000 | 2,793,000 |
Q4 2021 | 574,000 | 425,000 |
Q1 2022 | 300,000 | 356,000 |
Q2 2022 | 645,000 | 413,000 |
Q3 2022 | 350,000 | 157,000 |
Q4 2022 | 442,754 | 167,134 |
Q1 2023 | 16,205,000 | 0 |